This announcement is a separate document:
键凯科技：关于自愿披露聚乙二醇伊立替康用于治疗小细胞肺癌III期临床试验完成首例受试者入组的公告
Jiankai Technology: Announcement on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated